This inventor holds 1 USPTO granted patent. Top assignees: China Parmaceutical University, Chinese Academy of Medical Sciences. Active years: 2024.
Company Filing History:
1 out of 1 
1 out of 129 Years Active: 2024
Title: Runan Yu - Innovator in JAK Kinase Inhibitors
Introduction
Runan Yu is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of JAK kinase inhibitors. His work focuses on creating effective treatments for autoimmune diseases, showcasing his dedication to advancing healthcare solutions.
Latest Patents
Runan Yu holds a patent for the "Preparation for 6-amino-1H-pyrazolo[3,4-d]pyrimidine-based JAK kinase inhibitor and application thereof." This innovative medicament exhibits excellent JAK kinase inhibitory activity, which can be utilized to prevent, treat, and improve various autoimmune diseases, including psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, and systemic lupus erythematosus. The invention also includes a pharmaceutically acceptable composition containing the compound and a method for preparing these compounds.
Career Highlights
Throughout his career, Runan Yu has worked with esteemed institutions such as the Chinese Academy of Medical Sciences and China Pharmaceutical University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Runan Yu has collaborated with notable colleagues, including Tiantai Zhang and Dayong Zhang. These partnerships have further enriched his research and development efforts in the pharmaceutical industry.
Conclusion
Runan Yu's innovative work in the field of JAK kinase inhibitors highlights his commitment to improving treatments for autoimmune diseases. His contributions to medicinal chemistry are paving the way for advancements in healthcare.